Score Overview
Explore the 2021 public Archive ranking →
Where Utah Medical Products Inc has ranked, year by year
Showing 10 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- UTMD
2010: 97.0% · 2021: 48.9% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 74.49 | — |
1 Year2025-09-26 | $ 61.62 | 20.88% |
5 Years2021-09-28 | $ 87.27 | -14.64% |
10 Years2016-09-28 | $ 51.06 | 45.89% |
20 Years2006-09-28 | $ 20.34 | 266.14% |
30 Years1996-09-27 | $ 7.10 | 10x |
All Time1999-03-08 | $ 3.55 | 20x |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | 30 Years1996-09-27 | All Time1999-03-08 |
|---|---|---|---|---|---|---|---|
| Price | $ 74.49 | $ 61.62 | $ 87.27 | $ 51.06 | $ 20.34 | $ 7.10 | $ 3.55 |
| Return | — | 20.88% | -14.64% | 45.89% | 266.14% | 10x | 20x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 36M | $ 10M | $ 87M |
| 2025 | $ 38M | $ 11M | $ 85M |
| 2024 | $ 40M | $ 13M | $ 82M |
| 2023 | $ 50M | $ 16M | $ 92M |
| 2022 | $ 52M | $ 16M | $ 75M |
| 2021 | $ 49M | $ 14M | $ 60M |
| 2020 | $ 42M | $ 10M | $ 51M |
| 2019 | $ 46M | $ 14M | $ 42M |
| 2018 | $ 41M | $ 18M | $ 51M |
| 2017 | $ 41M | $ 8M | $ 39M |
| 2016 | $ 39M | $ 12M | $ 26M |
| 2015 | $ 40M | $ 11M | $ 23M |
| 2014 | $ 41M | $ 11M | $ 19M |
| 2013 | $ 40M | $ 11M | $ 14M |
| 2012 | $ 41M | $ 10M | $ 8M |
| 2011 | $ 37M | $ 7M | $ 6M |
| 2010 | $ 25M | $ 6M | $ 18M |
| 2009 | $ 25M | $ 6M | $ 19M |
| 2008 | $ 27M | $ 7M | $ 16M |
| 2007 | $ 28M | $ 7M | $ 22M |
| 2006 | $ 28M | $ 8M | $ 21M |
| 2005 | $ 27M | $ 7M | $ 17M |
| 2004 | $ 26M | $ 10M | $ 16M |
| 2003 | $ 27M | $ 20M | $ 1M |
| 2002 | $ 27M | $ 7M | $ 285K |
| 2001 | $ 26M | $ 5M | $ 370K |
| 2000 | $ 27M | $ 5M | $ 414K |
| IPO1999 | $ 29M | $ 5M | $ 647K |
Utah Medical Products Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 42M to $ 38M and net income grew from $ 10M to $ 11M. Revenue increased in 1 of those 5 years; net income in 2.
Across Utah Medical Products Inc's full reported history, from 1999 to 2025, revenue grew from $ 29M to $ 38M and net income grew from $ 5M to $ 11M. Revenue increased in 41% of the years measured; net income in 48%.
Utah Medical Products Inc currently holds a 20-year HDB Score of 4.0 out of 10. How the HDB Score is calculated.
Membership
Continue UTMD’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
